Literature DB >> 23271168

Validation of different sets of criteria for the diagnosis of Sjögren's syndrome in Japanese patients.

Hiroto Tsuboi1, Shinya Hagiwara, Hiromitsu Asashima, Hisanori Umehara, Atsushi Kawakami, Hideki Nakamura, Hajime Sano, Kazuo Tsubota, Yoko Ogawa, Etsuko Takamura, Ichiro Saito, Hiroko Inoue, Seiji Nakamura, Masafumi Moriyama, Tsutomu Takeuchi, Yoshiya Tanaka, Shintaro Hirata, Tsuneyo Mimori, Isao Matsumoto, Takayuki Sumida.   

Abstract

OBJECTIVE: To validate the revised Japanese Ministry of Health criteria for the diagnosis of Sjögren's syndrome (SS) (JPN) (1999), The American-European Consensus Group classification criteria for SS (AECG) (2002), and American College of Rheumatology classification criteria for SS (ACR) (2012).
METHODS: The study subjects were 694 patients with SS or suspected SS who were followed-up in June 2012 at ten hospitals that form part of the Research Team for Autoimmune Diseases, The Research Program for Intractable Disease by the Ministry of Health, Labor and Welfare (MHLW). All patients had been checked for all four criteria of the JPN (pathology, oral, ocular, anti-SS-A/SS-B antibodies). We studied the clinical diagnosis made by the physician in charge and the satisfaction of the above criteria.
RESULTS: Of the 694 patients, 499 patients did not have other connective tissue diseases (CTDs). SS was diagnosed in 476 patients (primary SS in 302, secondary SS in 174), whereas non-SS was diagnosed in 218 patients (without other CTDs in 197, with other CTDs in 21) by the physician in charge. The sensitivities of JPN, AECG, and ACR in the diagnosis of all forms of SS (both primary and secondary SS) were 79.6, 78.6, and 77.5 %, respectively, with respective specificities of 90.4, 90.4, and 83.5 %. The sensitivities of the same systems in the diagnosis of primary SS were 82.1, 83.1, and 79.1 %, respectively, with specificities of 90.9, 90.9, and 84.8 %, respectively. The sensitivities of the same systems in the diagnosis of secondary SS were 75.3, 70.7, and 74.7 %, respectively, with specificities of 85.7, 85.7, and 71.4 %, respectively.
CONCLUSION: The sensitivity of JPN to all forms of SS and secondary SS, the sensitivity of AECG to primary SS, and the specificities of JPN and AECG for all forms of SS, primary SS, and secondary SS were highest in the diagnosis of SS in Japanese patients. These results indicate that the JPN criteria for the diagnosis of SS in Japanese patients are superior to ACR and AECG.

Entities:  

Mesh:

Year:  2012        PMID: 23271168     DOI: 10.1007/s10165-012-0812-9

Source DB:  PubMed          Journal:  Mod Rheumatol        ISSN: 1439-7595            Impact factor:   3.023


  6 in total

1.  Comparison of the American-European Consensus Group Sjogren's syndrome classification criteria to newly proposed American College of Rheumatology criteria in a large, carefully characterised sicca cohort.

Authors:  Astrid Rasmussen; John A Ice; He Li; Kiely Grundahl; Jennifer A Kelly; Lida Radfar; Donald U Stone; Kimberly S Hefner; Juan-Manuel Anaya; Michael Rohrer; Rajaram Gopalakrishnan; Glen D Houston; David M Lewis; James Chodosh; John B Harley; Pamela Hughes; Jacen S Maier-Moore; Courtney G Montgomery; Nelson L Rhodus; A Darise Farris; Barbara M Segal; Roland Jonsson; Christopher J Lessard; R Hal Scofield; Kathy L Moser Sivils
Journal:  Ann Rheum Dis       Date:  2013-08-22       Impact factor: 19.103

2.  Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.

Authors:  Hiroto Tsuboi; Shinya Hagiwara; Hiromitsu Asashima; Hiroyuki Takahashi; Tomoya Hirota; Hisashi Noma; Hisanori Umehara; Atsushi Kawakami; Hideki Nakamura; Hajime Sano; Kazuo Tsubota; Yoko Ogawa; Etsuko Takamura; Ichiro Saito; Hiroko Inoue; Seiji Nakamura; Masafumi Moriyama; Tsutomu Takeuchi; Yoshiya Tanaka; Shintaro Hirata; Tsuneyo Mimori; Isao Matsumoto; Takayuki Sumida
Journal:  Ann Rheum Dis       Date:  2017-03-22       Impact factor: 19.103

3.  Level of agreement between 2002 American-European Consensus Group and 2012 American College of Rheumatology classification criteria for Sjögren's syndrome and reasons for discrepancies.

Authors:  Divi Cornec; Alain Saraux; Béatrice Cochener; Jacques-Olivier Pers; Sandrine Jousse-Joulin; Yves Renaudineau; Thierry Marhadour; Valérie Devauchelle-Pensec
Journal:  Arthritis Res Ther       Date:  2014-03-19       Impact factor: 5.156

4.  Identification of definitive serum biomarkers associated with disease activity in primary Sjögren's syndrome.

Authors:  Ayumi Nishikawa; Katsuya Suzuki; Yoshiaki Kassai; Yuumi Gotou; Maiko Takiguchi; Takahiro Miyazaki; Keiko Yoshimoto; Hidekata Yasuoka; Kunihiro Yamaoka; Rimpei Morita; Akihiko Yoshimura; Tsutomu Takeuchi
Journal:  Arthritis Res Ther       Date:  2016-05-14       Impact factor: 5.156

5.  Arterial Spin Labeling Imaging for the Parotid Glands of Patients with Sjögren's Syndrome.

Authors:  Yukiko N Kami; Misa Sumi; Yukinori Takagi; Miho Sasaki; Masataka Uetani; Takashi Nakamura
Journal:  PLoS One       Date:  2016-03-09       Impact factor: 3.240

6.  Prevalence of primary Sjögren's syndrome in patients undergoing evaluation for pulmonary arterial hypertension.

Authors:  Tatsuyuki Sato; Masaru Hatano; Yukiko Iwasaki; Hisataka Maki; Akihito Saito; Shun Minatsuki; Toshiro Inaba; Eisuke Amiya; Keishi Fujio; Masafumi Watanabe; Kazuhiko Yamamoto; Issei Komuro
Journal:  PLoS One       Date:  2018-05-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.